These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 25325386)

  • 1. Functional effects of botulinum toxin type-A treatment and subsequent stretching of spastic calf muscles: a study in patients with hereditary spastic paraplegia.
    de Niet M; de Bot ST; van de Warrenburg BP; Weerdesteyn V; Geurts AC
    J Rehabil Med; 2015 Feb; 47(2):147-53. PubMed ID: 25325386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional effects of botulinum toxin type A in the hip adductors and subsequent stretching in patients with hereditary spastic paraplegia.
    van Lith BJH; den Boer J; van de Warrenburg BPC; Weerdesteyn V; Geurts AC
    J Rehabil Med; 2019 Jun; 51(6):434-441. PubMed ID: 30968942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined Treatment Fkt-Botulinum Toxin Type A (Btx-A) in Patients with Strumpell-Lorrain Disease.
    Riccardo M; Angela L; Angela D; Vita P; Giulio L; Pietroq F; Giancarlo I; Marisa M
    Curr Pharm Des; 2016; 22(6):758-63. PubMed ID: 26648460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin injections for pediatric patients with hereditary spastic paraparesis.
    Geva-Dayan K; Domenievitz D; Zahalka R; Fattal-Valevski A
    J Child Neurol; 2010 Aug; 25(8):969-75. PubMed ID: 20406997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized Trial of Botulinum Toxin Type A in Hereditary Spastic Paraplegia - The SPASTOX Trial.
    Diniz de Lima F; Faber I; Servelhere KR; Bittar MFR; Martinez ARM; Piovesana LG; Martins MP; Martins CR; Benaglia T; de Sá Carvalho B; Nucci A; França MC
    Mov Disord; 2021 Jul; 36(7):1654-1663. PubMed ID: 33595142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin for hereditary spastic paraplegia: effects on motor and non-motor manifestations.
    Servelhere KR; Faber I; Martinez A; Nickel R; Moro A; Germiniani FMB; Moscovich M; Blume TR; Munhoz RP; Teive HAG; França MC
    Arq Neuropsiquiatr; 2018 Mar; 76(3):183-188. PubMed ID: 29809239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does calf muscle spasticity contribute to postural imbalance? A study in persons with pure hereditary spastic paraparesis.
    de Niet M; Weerdesteyn V; de Bot ST; van de Warrenburg BP; Geurts AC
    Gait Posture; 2013 Jun; 38(2):304-9. PubMed ID: 23433545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mobile digital gait analysis captures effects of botulinum toxin in hereditary spastic paraplegia.
    Ibrahim AA; Ollenschläger M; Klebe S; Schüle R; Jeschonneck N; Kellner M; Loris E; Greinwalder T; Eskofier BM; Winkler J; Gaßner H; Regensburger M
    Eur J Neurol; 2024 Aug; 31(8):e16367. PubMed ID: 38859620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin injection in patients with hereditary spastic paraparesis.
    Rousseaux M; Launay MJ; Kozlowski O; Daveluy W
    Eur J Neurol; 2007 Feb; 14(2):206-12. PubMed ID: 17250731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excessive short-latency stretch reflexes in the calf muscles do not cause postural instability in patients with hereditary spastic paraplegia.
    van Lith BJH; de Niet M; van de Warrenburg BPC; Geurts AC; Weerdesteyn V
    Clin Neurophysiol; 2019 Aug; 130(8):1188-1195. PubMed ID: 31163363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variability and predictability of functional efficacy of botulinum toxin injection in leg spastic muscles.
    Rousseaux M; Compère S; Launay MJ; Kozlowski O
    J Neurol Sci; 2005 May; 232(1-2):51-7. PubMed ID: 15850582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of Repetitive Transcranial Magnetic Stimulation on Motor Symptoms in Hereditary Spastic Paraplegia.
    Antczak J; Pera J; Dąbroś M; Koźmiński W; Czyżycki M; Wężyk K; Dwojak M; Banach M; Slowik A
    Neural Plast; 2019; 2019():7638675. PubMed ID: 31214256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind randomised placebo-controlled evaluation of three doses of botulinum toxin type A (Dysport) in the treatment of spastic equinovarus deformity after stroke.
    Pittock SJ; Moore AP; Hardiman O; Ehler E; Kovac M; Bojakowski J; Al Khawaja I; Brozman M; Kanovský P; Skorometz A; Slawek J; Reichel G; Stenner A; Timerbaeva S; Stelmasiak Z; Zifko UA; Bhakta B; Coxon E
    Cerebrovasc Dis; 2003; 15(4):289-300. PubMed ID: 12686794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Online monitoring of focal spasticity treatment with botulinum toxin in people with chronic stroke or hereditary spastic paraplegia: a feasibility study.
    Kerstens HCJW; Nijkrake MJ; De Swart BJM; Nijhuis-van der Sanden RWG; Vos-van de Hulst M; Bos GJ; Geurts ACH; Van der Wees PJ
    J Rehabil Med; 2023 Apr; 55():jrm00383. PubMed ID: 37073790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isokinetic assessment of the effects of botulinum toxin injection on spasticity and voluntary strength in patients with spastic hemiparesis.
    Hameau S; Bensmail D; Robertson J; Boudarham J; Roche N; Zory R
    Eur J Phys Rehabil Med; 2014 Oct; 50(5):515-23. PubMed ID: 24651151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gait analysis of sporadic and hereditary spastic paraplegia.
    Klebe S; Stolze H; Kopper F; Lorenz D; Wenzelburger R; Volkmann J; Porschke H; Deuschl G
    J Neurol; 2004 May; 251(5):571-8. PubMed ID: 15164190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Balance rehabilitation with a virtual reality protocol for patients with hereditary spastic paraplegia: Protocol for a clinical trial.
    Zeigelboim BS; José MR; Santos GJBD; Severiano MIR; Teive HAG; Stechman-Neto J; Santos RS; de Araújo CM; Cavalcante-Leão BL
    PLoS One; 2021; 16(4):e0249095. PubMed ID: 33793609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of botulinum toxin A on calf muscles in children with cerebral palsy: a systematic review.
    Koog YH; Min BI
    Clin Rehabil; 2010 Aug; 24(8):685-700. PubMed ID: 20554641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined effects of robot‑assisted gait training and botulinum toxin type A on spastic equinus foot in patients with chronic stroke: a pilot, single blind, randomized controlled trial.
    Picelli A; Bacciga M; Melotti C; LA Marchina E; Verzini E; Ferrari F; Pontillo A; Corradi J; Tamburin S; Saltuari L; Corradini C; Waldner A; Smania N
    Eur J Phys Rehabil Med; 2016 Dec; 52(6):759-766. PubMed ID: 27098300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional outcome following Botulinum toxin A injection to reduce spastic equinus in adults with traumatic brain injury.
    Fock J; Galea MP; Stillman BC; Rawicki B; Clark M
    Brain Inj; 2004 Jan; 18(1):57-63. PubMed ID: 14660236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.